Abstract:Mast cells are well accepted as important sentinel cells for host defence against selected pathogens. Their location at mucosal surfaces and ability to mobilize multiple aspects of early immune responses makes them critical contributors to effective immunity in several experimental settings. However, the interactions of mast cells with viruses and pathogen products are complex and can have both detrimental and positive impacts. There is substantial evidence for mast cell mobilization and activation of effector cells and mobilization of dendritic cells following viral challenge. These cells are a major and under-appreciated local source of type I and III interferons following viral challenge. However, mast cells have also been implicated in inappropriate inflammatory responses, long term fibrosis, and vascular leakage associated with viral infections. Progress in combating infection and boosting effective immunity requires a better understanding of mast cell responses to viral infection and the pathogen products and receptors we can employ to modify such responses. In this review, we outline some of the key known responses of mast cells to viral infection and their major responses to pathogen products. We have placed an emphasis on data obtained from human mast cells and aim to provide a framework for considering the complex interactions between mast cells and pathogens with a view to exploiting this knowledge therapeutically. Long-lived resident mast cells and their responses to viruses and pathogen products provide excellent opportunities to modify local immune responses that remain to be fully exploited in cancer immunotherapy, vaccination, and treatment of infectious diseases.

Highlight of 2023: Advances in mast cells

Rearch Progress on the Relationship Between Mast Cells and Cancer

New perspectives on the origins and heterogeneity of mast cells

Highlight of 2023: Unconventional T cells: recent insights on development, trafficking and target cell recognition

Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases

The ingenious mast cell: Contemporary insights into mast cell behavior and function

Highlight of 2023: big impacts of microRNAs in T cells

New Insight into Intestinal Mast Cells Revealed by Single-Cell RNA Sequencing

Mast Cell Responses to Viruses and Pathogen Products

Highlight of 2023: From fundamental studies to clinical trials, the importance of NK cells against cancer

Advances and challenges in investigating B-cells via single-cell transcriptomics

Mast Cells in Human Health and Diseases 2.0

Single cell transcriptomics reveal mast cell heterogeneity in the human gut

Mast Cells: A New Frontier for Cancer Immunotherapy

Highlight of 2023: Unlocking the therapeutic potential of natural killer cells—advances in adaptive functions, cellular engineering and immunotherapy

B cell heterogeneity in cancer comes of age

Highlight of 2023: The metabolic symphony – orchestrating T‐cell immunity

Focus on Mast Cells in the Tumor Microenvironment: Current Knowledge and Future Directions.

Unraveling the Complexities of Mast Cells in Health and Disease

Future Needs in Mast Cell Biology

Molecular mechanisms governing circulating immune cell heterogeneity across different species revealed by single‐cell sequencing